BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

706 related articles for article (PubMed ID: 29976663)

  • 1. PARP1 Stabilizes CTCF Binding and Chromatin Structure To Maintain Epstein-Barr Virus Latency Type.
    Lupey-Green LN; Caruso LB; Madzo J; Martin KA; Tan Y; Hulse M; Tempera I
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The three-dimensional structure of Epstein-Barr virus genome varies by latency type and is regulated by PARP1 enzymatic activity.
    Morgan SM; Tanizawa H; Caruso LB; Hulse M; Kossenkov A; Madzo J; Keith K; Tan Y; Boyle S; Lieberman PM; Tempera I
    Nat Commun; 2022 Jan; 13(1):187. PubMed ID: 35039491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PARP1 restricts Epstein Barr Virus lytic reactivation by binding the BZLF1 promoter.
    Lupey-Green LN; Moquin SA; Martin KA; McDevitt SM; Hulse M; Caruso LB; Pomerantz RT; Miranda JL; Tempera I
    Virology; 2017 Jul; 507():220-230. PubMed ID: 28456021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivation of Epstein-Barr Virus from Latency Involves Increased RNA Polymerase Activity at CTCF Binding Sites on the Viral Genome.
    Dunn LEM; Lu F; Su C; Lieberman PM; Baines JD
    J Virol; 2023 Feb; 97(2):e0189422. PubMed ID: 36744959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr Virus Oncoprotein LMP1 Mediates Epigenetic Changes in Host Gene Expression through PARP1.
    Martin KA; Lupey LN; Tempera I
    J Virol; 2016 Oct; 90(19):8520-30. PubMed ID: 27440880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CCCTC Binding Factor, CTRL2, Modulates Heterochromatin Deposition and the Establishment of Herpes Simplex Virus 1 Latency
    Washington SD; Singh P; Johns RN; Edwards TG; Mariani M; Frietze S; Bloom DC; Neumann DM
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30996085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr Virus Rta-Mediated Accumulation of DNA Methylation Interferes with CTCF Binding in both Host and Viral Genomes.
    Chen YJ; Chen YL; Chang Y; Wu CC; Ko YC; Tsao SW; Chen JY; Lin SF
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28490592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTCF prevents the epigenetic drift of EBV latency promoter Qp.
    Tempera I; Wiedmer A; Dheekollu J; Lieberman PM
    PLoS Pathog; 2010 Aug; 6(8):e1001048. PubMed ID: 20730088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone Loaders CAF1 and HIRA Restrict Epstein-Barr Virus B-Cell Lytic Reactivation.
    Zhang Y; Jiang C; Trudeau SJ; Narita Y; Zhao B; Teng M; Guo R; Gewurz BE
    mBio; 2020 Oct; 11(5):. PubMed ID: 33109754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCF1 and OCT2 Cooperate with EBNA1 To Enhance OriP-Dependent Transcription and Episome Maintenance of Latent Epstein-Barr Virus.
    Dheekollu J; Wiedmer A; Sentana-Lledo D; Cassel J; Messick T; Lieberman PM
    J Virol; 2016 Jun; 90(11):5353-5367. PubMed ID: 27009953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF.
    Chau CM; Zhang XY; McMahon SB; Lieberman PM
    J Virol; 2006 Jun; 80(12):5723-32. PubMed ID: 16731911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contributions of CTCF and DNA methyltransferases DNMT1 and DNMT3B to Epstein-Barr virus restricted latency.
    Hughes DJ; Marendy EM; Dickerson CA; Yetming KD; Sample CE; Sample JT
    J Virol; 2012 Jan; 86(2):1034-45. PubMed ID: 22072770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr Virus Viral Processivity Factor EA-D Facilitates Virus Lytic Replication by Inducing Poly(ADP-Ribose) Polymerase 1 Degradation.
    Lee S; Kim J; Chung WC; Han JH; Song MJ
    J Virol; 2022 Nov; 96(21):e0037122. PubMed ID: 36286483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection.
    Price AM; Messinger JE; Luftig MA
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EBV latency types adopt alternative chromatin conformations.
    Tempera I; Klichinsky M; Lieberman PM
    PLoS Pathog; 2011 Jul; 7(7):e1002180. PubMed ID: 21829357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCCTC-Binding Factor Acts as a Heterochromatin Barrier on Herpes Simplex Viral Latent Chromatin and Contributes to Poised Latent Infection.
    Lee JS; Raja P; Pan D; Pesola JM; Coen DM; Knipe DM
    mBio; 2018 Feb; 9(1):. PubMed ID: 29437926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1.
    Hulse M; Caruso LB; Madzo J; Tan Y; Johnson S; Tempera I
    PLoS Pathog; 2018 Nov; 14(11):e1007394. PubMed ID: 30395643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-Dimensional Chromatin Structure of the EBV Genome: A Crucial Factor in Viral Infection.
    Caruso LB; Maestri D; Tempera I
    Viruses; 2023 Apr; 15(5):. PubMed ID: 37243174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1.
    Bentz GL; Moss CR; Whitehurst CB; Moody CA; Pagano JS
    J Virol; 2015 Aug; 89(15):7465-77. PubMed ID: 25948750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The three-dimensional structure of the EBV genome plays a crucial role in regulating viral gene expression in EBVaGC.
    Maestri D; Napoletani G; Kossenkov A; Preston-Alp S; Caruso LB; Tempera I
    Nucleic Acids Res; 2023 Dec; 51(22):12092-12110. PubMed ID: 37889078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.